ibuprofen

ibuprofen is a nonsteroidal anti-inflammatory drug used to reduce fever, pain, and inflammation. It is widely employed for conditions ranging from headache and musculoskeletal pain to dysmenorrhea and fever, and is available in over-the-counter and prescription forms. First introduced in the 1960s, it has become one of the most commonly used analgesics worldwide.

Medical uses

Ibuprofen is indicated for symptomatic relief in acute pain and chronic conditions. It is used for headache, migraine, dental pain, musculoskeletal injuries, osteoarthritis, and rheumatoid arthritis, and for reducing fever in adults and children. Clinicians also prescribe it for dysmenorrhea and postoperative pain management. In settings such as primary care, emergency departments, and sports medicine, ibuprofen is used alongside nonpharmacologic measures and other agents like acetaminophen, aspirin, and opioid analgesics when appropriate.

Adverse effects and safety

Common adverse effects include gastrointestinal discomfort, dyspepsia, and risk of gastrointestinal ulceration with prolonged use. Serious risks encompass upper gastrointestinal bleeding and perforation, renal impairment including acute kidney injury, and exacerbation of hypertension or heart failure in susceptible individuals. There is an association between nonsteroidal anti-inflammatory drugs and increased cardiovascular thrombotic events, including myocardial infarction and stroke, particularly at higher doses and prolonged treatment. Hypersensitivity reactions ranging from urticaria to anaphylaxis can occur, and bronchospasm may be precipitated in patients with aspirin-exacerbated respiratory disease. Use in pregnancy, especially in the third trimester, is generally contraindicated because of risks such as premature closure of the fetal ductus arteriosus and oligohydramnios.

Pharmacology

Ibuprofen exerts its therapeutic effects through reversible inhibition of cyclooxygenase enzymes, reducing prostaglandin synthesis. It inhibits both COX-1 and COX-2 isoforms, leading to decreased formation of prostaglandins involved in nociception, inflammation, and fever. The drug is rapidly absorbed after oral administration, reaching peak plasma concentrations usually within 1–2 hours; food delays absorption but does not reduce overall bioavailability. It is extensively bound to plasma proteins and undergoes hepatic metabolism primarily by cytochrome P450 enzymes to inactive metabolites, which are excreted in urine. The enantiomers of ibuprofen show stereoselective pharmacokinetics and pharmacodynamics; the S-(+) enantiomer is the pharmacologically active form, while the R-(−) enantiomer can be converted to the S-form in vivo.

Chemistry and formulation

Chemically, ibuprofen is a propionic acid derivative with a molecular structure characterized by an arylpropionic acid core. It is a chiral molecule commonly administered as a racemic mixture or as formulations enriched for the active enantiomer. Formulations include immediate-release tablets, enteric-coated tablets, chewable tablets, suspensions for pediatric use, intravenous preparations for hospital use, and topical gels or creams for local musculoskeletal application. Combination products pair ibuprofen with other agents such as diphenhydramine, pseudoephedrine, or opioid analgesics in prescription settings. Excipients and formulation technologies such as solubilizers, microencapsulation, and salt forms are used to modulate onset of action, gastrointestinal tolerability, and bioavailability in various commercial products.

History and society

Research leading to ibuprofen began amid efforts to find alternatives to earlier analgesics. Early clinical development involved researchers and institutions active in the United Kingdom and Europe during the mid-20th century. The drug entered clinical use following trials that compared its efficacy and safety to existing agents and was commercialized by pharmaceutical companies operating in major markets such as the United Kingdom, the United States, and continental Europe. Over decades, ibuprofen has featured in debates about nonsteroidal anti-inflammatory drug safety, pharmaceutical marketing practices, and over-the-counter availability. It has been included in treatment guidelines for common conditions and is listed on essential medicines lists maintained by global health organizations. Cultural and economic factors have influenced its prominence in self-care, pharmacy practice, and clinical formularies across diverse healthcare systems.

Regulatory status and availability

Ibuprofen is available over the counter for many countries in low-dose formulations and by prescription in higher-strength formulations. Regulatory agencies and national drug authorities assess indications, labeling, and risk mitigation measures, often issuing guidance on use in pregnancy, cardiovascular risk, and co-administration with other medications. Marketed products vary by brand name, strength, dosage form, and approved indications across jurisdictions. Public health advisories and pharmacoepidemiologic surveillance continue to inform regulatory actions, including restrictions, label updates, and communications to prescribers and consumers regarding safe use.